Paul M. Keane

Consumer Services

Health Technology

Process Industries

Profile

Paul M.
Keane has been Director-Medical Affairs of YM BioSciences, Inc. since 1996.
Dr. Keane was Director of Clinical Research of Miles Canada, Inc. from 1989 to 1995.
He was Professor of Medicine for the University of Calgary.

Former positions of Paul M. Keane

Companies	Position	End
Bayer, Inc. Bayer, Inc. Chemicals: AgriculturalProcess Industries Bayer, Inc. manufactures chemicals, healthcare, agricultural, and life science products. The company develops products that fight diseases, protects crops and animals, as well as develops materials. It was founded in 1936 and is headquartered in Toronto, Canada	Chief Tech/Sci/R&D Officer	31/12/1994
McMaster University	Corporate Officer/Principal	-
University of Calgary	Corporate Officer/Principal	-
YM BioSciences, Inc. YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada.	Chief Tech/Sci/R&D Officer	-

See the detail of Paul M. Keane's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Paul M. Keane's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
YM BioSciences, Inc. YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada.	Health Technology
Bayer, Inc. Bayer, Inc. Chemicals: AgriculturalProcess Industries Bayer, Inc. manufactures chemicals, healthcare, agricultural, and life science products. The company develops products that fight diseases, protects crops and animals, as well as develops materials. It was founded in 1936 and is headquartered in Toronto, Canada	Process Industries